These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16158268)
21. [Vector-mediated HER-2 RNA interference against HER-2-positive breast cancer]. Hu XQ; Qin L; Su FX; Yao HR; Chen JS; Gong C; Guo JJ; Yu FY; Jia HX Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):570-2. PubMed ID: 16762851 [TBL] [Abstract][Full Text] [Related]
22. [Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3]. Xu J; Liu C; Yu XJ; Jin C; Fu DL; Ni QX Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1948-51. PubMed ID: 19062732 [TBL] [Abstract][Full Text] [Related]
23. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [TBL] [Abstract][Full Text] [Related]
24. Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Dong AQ; Kong MJ; Ma ZY; Qian JF; Xu XH Cell Biol Int; 2007 May; 31(5):500-7. PubMed ID: 17196841 [TBL] [Abstract][Full Text] [Related]
25. Characterization of human UDP-glucose dehydrogenase reveals critical catalytic roles for lysine 220 and aspartate 280. Easley KE; Sommer BJ; Boanca G; Barycki JJ; Simpson MA Biochemistry; 2007 Jan; 46(2):369-78. PubMed ID: 17209547 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range. Meryet-Figuières M; Resina S; Lavigne C; Barlovatz-Meimon G; Lebleu B; Thierry AR Biochimie; 2007 Oct; 89(10):1228-33. PubMed ID: 17509745 [TBL] [Abstract][Full Text] [Related]
27. [Inhibition of ovarian cancer growth by small interfering RNA targeting X-linked inhibitor of apoptosis gene]. Ma JJ; Chen BL; Xin XY Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):124-8. PubMed ID: 17442189 [TBL] [Abstract][Full Text] [Related]
28. [Effect of RNAi-mediated gene silencing of C-erbB-2 on proliferation of lung adenocarcinoma cell line calu-3]. Ren SH; Zhang W; Qu P; Liu Y; Wang JW; Zhang L Ai Zheng; 2005 Oct; 24(10):1173-8. PubMed ID: 16219128 [TBL] [Abstract][Full Text] [Related]
29. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference. Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596 [TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effects of RNA interference on expression of matrix metalloproteinase-9 gene and invasiveness and adhesion in ovarian cancer cells]. Hu XX; Li L; Li DR; Zhang W; Tang BJ Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):579-83. PubMed ID: 17181964 [TBL] [Abstract][Full Text] [Related]
31. [siRNA-mediated inhibition of ErbB2 expression and its effect on breast cancer cell growth]. Jiang K; Yang ZH; Wang ZY; Xu XJ; Cheng L; Zhang H; Han YJ; Ye QN Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):257-9. PubMed ID: 21419042 [TBL] [Abstract][Full Text] [Related]
32. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Zhang H; Pelzer AM; Kiang DT; Yee D Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722 [TBL] [Abstract][Full Text] [Related]
34. Effects of xenobiotics and peroxisome proliferator-activated receptor-alpha on the human UDPglucose dehydrogenase gene expression. Vatsyayan J; Lee SJ; Chang HY J Biochem Mol Toxicol; 2005; 19(5):279-88. PubMed ID: 16292757 [TBL] [Abstract][Full Text] [Related]
35. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma. Guo B; Zhang Y; Luo G; Li L; Zhang J Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240 [TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus latent membrane protein 2A upregulates UDP-glucose dehydrogenase gene expression via ERK and PI3K/Akt pathway. Pan YR; Vatsyayan J; Chang YS; Chang HY Cell Microbiol; 2008 Dec; 10(12):2447-60. PubMed ID: 18717819 [TBL] [Abstract][Full Text] [Related]
38. Reconstruction of de novo pathway for synthesis of UDP-glucuronic acid and UDP-xylose from intrinsic UDP-glucose in Saccharomyces cerevisiae. Oka T; Jigami Y FEBS J; 2006 Jun; 273(12):2645-57. PubMed ID: 16817893 [TBL] [Abstract][Full Text] [Related]
39. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells. Ge YL; Zhang X; Zhang JY; Hou L; Tian RH Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240 [TBL] [Abstract][Full Text] [Related]
40. Regulation of UDP-glucose dehydrogenase is sufficient to modulate hyaluronan production and release, control sulfated GAG synthesis, and promote chondrogenesis. Clarkin CE; Allen S; Kuiper NJ; Wheeler BT; Wheeler-Jones CP; Pitsillides AA J Cell Physiol; 2011 Mar; 226(3):749-61. PubMed ID: 20717929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]